VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q56944167  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000204.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q56944167‏
024 ‎‡a  0000-0002-0326-0495‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q56944167‏
100 0 ‎‡a  Johnson George‏ ‎‡9  es‏ ‎‡9  ast‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  জনসন জর্জ‏ ‎‡9  bn‏
400 0 ‎‡a  Johnson George‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Johnson George‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial).‏
670 ‎‡a  Author's A pharmacist-led intervention for increasing the uptake of Home Medicines Review‏
670 ‎‡a  Author's A pharmacist-led intervention for increasing the uptake of Home Medicines Review (HMR) among residents of retirement villages (PHARMER): protocol for a cluster randomised controlled trial‏
670 ‎‡a  Author's A pharmacist-led system-change smoking cessation intervention for smokers admitted to Australian public hospitals (GIVE UP FOR GOOD): study protocol for a randomised controlled trial‏
670 ‎‡a  Author's A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART CVD pilot project‏
670 ‎‡a  Author's A pilot study to investigate the scope for an inpatient smoking cessation programme‏
670 ‎‡a  Author's A prospective cohort study of pulmonary function during pregnancy in women with and without asthma‏
670 ‎‡a  Author's A Review of Electronic Devices to Assess Inhaler Technique.‏
670 ‎‡a  Author's A systematic narrative review of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups‏
670 ‎‡a  Author's A systematic narrative review of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups (2010-2017).‏
670 ‎‡a  Author's Adherence to disease management programs in patients with COPD.‏
670 ‎‡a  Author's An exploration of the role of pharmacists within general practice clinics: the protocol for the pharmacists in practice study‏
670 ‎‡a  Author's An exploration of the role of pharmacists within general practice clinics: the protocol for the pharmacists in practice study (PIPS).‏
670 ‎‡a  Author's Asthma, bones and corticosteroids: Are inhaled corticosteroids associated with fractures in children with asthma?‏
670 ‎‡a  Author's Asthma during Pregnancy: The Experiences, Concerns and Views of Pregnant Women with Asthma‏
670 ‎‡a  Author's Asthma in Pregnancy: Are Inhaled Corticosteroids Safe?‏
670 ‎‡a  Author's Benefits and challenges of prescribing training and implementation: perceptions and early experiences of RPSGB prescribers‏
670 ‎‡a  Author's Can a redesign of emergency pharmacist roles improve medication management? A prospective study in three Australian hospitals.‏
670 ‎‡a  Author's Challenges in measuring medication adherence: experiences from a controlled trial‏
670 ‎‡a  Author's Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review.‏
670 ‎‡a  Author's Comorbid tobacco and other substance use and symptoms of anxiety and depression among hospitalised orthopaedic trauma patients‏
670 ‎‡a  Author's Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?‏
670 ‎‡a  Author's COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update‏
670 ‎‡a  Author's Cross sectional survey of the Scottish general public's awareness of, views on, and attitudes toward nonmedical prescribing‏
670 ‎‡a  Author's Developing and validating a tool for assessment of pharmacist prescribers' consultations‏
670 ‎‡a  Author's Development and validation of a 21-item challenges to stopping smoking (CSS-21) scale‏
670 ‎‡a  Author's Development and validation of the Beliefs and Behaviour Questionnaire‏
670 ‎‡a  Author's Development and validation of the Beliefs and Behaviour Questionnaire (BBQ).‏
670 ‎‡a  Author's Development and validation of the medication-based disease burden index.‏
670 ‎‡a  Author's Development and Validation of the Medication Regimen Complexity Index‏
670 ‎‡a  Author's Development of an online smoking cessation program for use in hospital and following discharge: smoke-free recovery‏
670 ‎‡a  Author's Diagnosing COPD and supporting smoking cessation in general practice: evidence-practice gaps‏
670 ‎‡a  Author's Dietary Supplement Use in Older People Attending Memory Clinics in Australia‏
670 ‎‡a  Author's Educating nonmedical prescribers‏
670 ‎‡a  Author's Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study‏
670 ‎‡a  Author's Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial.‏
670 ‎‡a  Author's Experiential learning as part of pharmacist supplementary prescribing training: feedback from trainees and their mentors‏
670 ‎‡a  Author's Exploring patients' perspectives of pharmacist supplementary prescribing in Scotland.‏
670 ‎‡a  Author's Exploring stakeholder perspectives on medication review services for older residents in retirement villages‏
670 ‎‡a  Author's Factors associated with medication nonadherence in patients with COPD.‏
670 ‎‡a  Author's Factors associated with nicotine replacement therapy use among hospitalised smokers‏
670 ‎‡a  Author's Hospital Smoke-Free Policy: Compliance, Enforcement, and Practices. A Staff Survey in Two Large Public Hospitals in Australia‏
670 ‎‡a  Author's Impact of a self-administration of medications programme on elderly inpatients' competence to manage medications: a pilot study‏
670 ‎‡a  Author's Impact of an intervention to reduce medication regimen complexity for older hospital inpatients.‏
670 ‎‡a  Author's Improving osteoporosis management in general practice: a pharmacist-led drug use evaluation program‏
670 ‎‡a  Author's Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists‏
670 ‎‡a  Author's Integrating smoking cessation into routine care in hospitals--a randomized controlled trial‏
670 ‎‡a  Author's Integration of pharmacists into general practice clinics in Australia: the views of general practitioners and pharmacists.‏
670 ‎‡a  Author's Interdisciplinary COPD intervention in primary care: a cluster randomised controlled trial‏
670 ‎‡a  Author's Interdisciplinary model of care (RADICALS) for early detection and management of chronic obstructive pulmonary disease (COPD) in Australian primary care: study protocol for a cluster randomised controlled trial‏
670 ‎‡a  Author's Intervention fidelity for a complex behaviour change intervention in community pharmacy addressing cardiovascular disease risk.‏
670 ‎‡a  Author's Interventions for improving medication‐taking ability and adherence in older adults prescribed multiple medications.‏
670 ‎‡a  Author's Management of asthma by pregnant women attending an Australian maternity hospital‏
670 ‎‡a  Author's Management of asthma in pregnant women by general practitioners: a cross sectional survey‏
670 ‎‡a  Author's Management of pregnancies complicated by hypertensive disorders of pregnancy: Could we do better?‏
670 ‎‡a  Author's Medication management for community palliative care patients and the role of a specialist palliative care pharmacist: A qualitative exploration of consumer and health care professional perspectives‏
670 ‎‡a  Author's Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital‏
670 ‎‡a  Author's Multidisciplinary Approach to Management of Maternal Asthma‏
670 ‎‡a  Author's Multidisciplinary Approach to Management of Maternal Asthma (MAMMA)‏
670 ‎‡a  Author's Multidisciplinary approach to management of maternal asthma (MAMMA [copyright]): the PROTOCOL for a randomized controlled trial‏
670 ‎‡a  Author's Nicotine replacement therapy: evidence from observational studies versus clinical trials‏
670 ‎‡a  Author's Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.‏
670 ‎‡a  Author's Optimising medication use during pregnancy: the potential role of pharmacists‏
670 ‎‡a  Author's Pharmacist Consultation Assessment Tool‏
670 ‎‡a  Author's Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).‏
670 ‎‡a  Author's Pharmacist prescribing in primary care: the views of patients across Great Britain who had experienced the service‏
670 ‎‡a  Author's Pharmacist services provided in general practice clinics: a systematic review and meta-analysis.‏
670 ‎‡a  Author's Pharmacist supplementary prescribing training: a study of pharmacists' perceptions and planned participation‏
670 ‎‡a  Author's Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics‏
670 ‎‡a  Author's Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia‏
670 ‎‡a  Author's Prescription medications: beliefs, experiences, behavior, and adherence of sheltered housing residents‏
670 ‎‡a  Author's Prevalence of medication-related risk factors among retirement village residents: a cross-sectional survey‏
670 ‎‡a  Author's Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.‏
670 ‎‡a  Author's Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers‏
670 ‎‡a  Author's Risk factors for medication misadventure among residents in sheltered housing complexes‏
670 ‎‡a  Author's Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis.‏
670 ‎‡a  Author's Smoke-Free Recovery from Trauma Surgery: A Pilot Trial of an Online Smoking Cessation Program for Orthopaedic Trauma Patients‏
670 ‎‡a  Author's Smoking, Quitting, and the Provision of Smoking Cessation Support: A Survey of Orthopaedic Trauma Patients‏
670 ‎‡a  Author's Smoking rates and smoking cessation preferences of pregnant women attending antenatal clinics of two large Australian maternity hospitals‏
670 ‎‡a  Author's Stakeholder experiences with general practice pharmacist services: a qualitative study‏
670 ‎‡a  Author's Study protocol for a randomised controlled trial evaluating the efficacy of a telehealth program--management of asthma with supportive telehealth of respiratory function in pregnancy (MASTERY©).‏
670 ‎‡a  Author's Supplementary prescribing: early experiences of pharmacists in Great Britain‏
670 ‎‡a  Author's System change interventions for smoking cessation.‏
670 ‎‡a  Author's Systematic review of the safety of regular preventive asthma medications during pregnancy‏
670 ‎‡a  Author's Tackling tobacco smoking: opportunities for pharmacists‏
670 ‎‡a  Author's Telehealth to improve asthma control in pregnancy: A randomized controlled trial‏
670 ‎‡a  Author's The effectiveness of non-pharmacological healthcare interventions for asthma management during pregnancy: a systematic review‏
670 ‎‡a  Author's The potential role of pharmacists in chronic disease screening‏
670 ‎‡a  Author's The Prevalence and Nature of Medication Errors and Adverse Events Related to Preadmission Medications When Patients Are Admitted to an Orthopedic Inpatient Unit: An Observational Study‏
670 ‎‡a  Author's The roles of community pharmacists in cardiovascular disease prevention and management.‏
670 ‎‡a  Author's Treatable traits in an English cohort: prevalence and predictors of future decline in lung function and quality of life in COPD‏
670 ‎‡a  Author's Uptake and effectiveness of a community pharmacy intervention programme to improve asthma management.‏
670 ‎‡a  Author's Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation.‏
670 ‎‡a  Author's Views of pharmacists and mentors on experiential learning for pharmacist supplementary prescribing trainees.‏
670 ‎‡a  Author's Views of the Scottish general public on non-medical prescribing‏
670 ‎‡a  Author's Who is More Likely to Use the Internet for Health Behavior Change? A Cross-Sectional Survey of Internet Use Among Smokers and Nonsmokers Who Are Orthopedic Trauma Patients.‏
909 ‎‡a  (orcid) 0000000203260495‏ ‎‡9  1‏
919 ‎‡a  asthmainpregnancyareinhaledcorticosteroidssafe‏ ‎‡A  Asthma in Pregnancy: Are Inhaled Corticosteroids Safe?‏ ‎‡9  1‏
919 ‎‡a  asthmaduringpregnancytheexperiencesconcernsandviewsofpregnantwomenwithasthma‏ ‎‡A  Asthma during Pregnancy: The Experiences, Concerns and Views of Pregnant Women with Asthma‏ ‎‡9  1‏
919 ‎‡a  asthmabonesandcorticosteroidsareinhaledcorticosteroidsassociatedwithfracturesinchildrenwithasthma‏ ‎‡A  Asthma, bones and corticosteroids: Are inhaled corticosteroids associated with fractures in children with asthma?‏ ‎‡9  1‏
919 ‎‡a  explorationoftheroleofpharmacistswithingeneralpracticeclinicstheprotocolforthepharmacistsinpracticestudypips‏ ‎‡A  An exploration of the role of pharmacists within general practice clinics: the protocol for the pharmacists in practice study (PIPS).‏ ‎‡9  1‏
919 ‎‡a  explorationoftheroleofpharmacistswithingeneralpracticeclinicstheprotocolforthepharmacistsinpracticestudy‏ ‎‡A  An exploration of the role of pharmacists within general practice clinics: the protocol for the pharmacists in practice study‏ ‎‡9  1‏
919 ‎‡a  adherencetodiseasemanagementprogramsinpatientswithcopd‏ ‎‡A  Adherence to disease management programs in patients with COPD.‏ ‎‡9  1‏
919 ‎‡a  systematicnarrativereviewoftheeffectivenessofbehaviouralsmokingcessationinterventionsinselecteddisadvantagedgroups2010‏ ‎‡A  A systematic narrative review of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups (2010-2017).‏ ‎‡9  1‏
919 ‎‡a  systematicnarrativereviewoftheeffectivenessofbehaviouralsmokingcessationinterventionsinselecteddisadvantagedgroups‏ ‎‡A  A systematic narrative review of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups‏ ‎‡9  1‏
919 ‎‡a  reviewofelectronicdevicestoassessinhalertechnique‏ ‎‡A  A Review of Electronic Devices to Assess Inhaler Technique.‏ ‎‡9  1‏
919 ‎‡a  prospectivecohortstudyofpulmonaryfunctionduringpregnancyinwomenwithandwithoutasthma‏ ‎‡A  A prospective cohort study of pulmonary function during pregnancy in women with and without asthma‏ ‎‡9  1‏
919 ‎‡a  pilotstudytoinvestigatethescopeforaninpatientsmokingcessationprogramme‏ ‎‡A  A pilot study to investigate the scope for an inpatient smoking cessation programme‏ ‎‡9  1‏
919 ‎‡a  pilotstudyevaluatingmultipleriskfactorinterventionsbycommunitypharmaciststopreventcardiovasculardiseasethepaartcvdpilotproject‏ ‎‡A  A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART CVD pilot project‏ ‎‡9  1‏
919 ‎‡a  pharmacistledsystemchangesmokingcessationinterventionforsmokersadmittedtoaustralianpublichospitalsgiveupforgoodstudyprotocolforarandomisedcontrolledtrial‏ ‎‡A  A pharmacist-led system-change smoking cessation intervention for smokers admitted to Australian public hospitals (GIVE UP FOR GOOD): study protocol for a randomised controlled trial‏ ‎‡9  1‏
919 ‎‡a  pharmacistledinterventionforincreasingtheuptakeofhomemedicinesreviewhmramongresidentsofretirementvillagespharmerprotocolforaclusterrandomisedcontrolledtrial‏ ‎‡A  A pharmacist-led intervention for increasing the uptake of Home Medicines Review (HMR) among residents of retirement villages (PHARMER): protocol for a cluster randomised controlled trial‏ ‎‡9  1‏
919 ‎‡a  pharmacistledinterventionforincreasingtheuptakeofhomemedicinesreview‏ ‎‡A  A pharmacist-led intervention for increasing the uptake of Home Medicines Review‏ ‎‡9  1‏
919 ‎‡a  multifacetedpharmacistinterventiontoimproveantihypertensiveadherenceaclusterrandomizedcontrolledtrialhappytrial‏ ‎‡A  A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial).‏ ‎‡9  1‏
919 ‎‡a  comorbidtobaccoandothersubstanceuseandsymptomsofanxietyanddepressionamonghospitalisedorthopaedictraumapatients‏ ‎‡A  Comorbid tobacco and other substance use and symptoms of anxiety and depression among hospitalised orthopaedic trauma patients‏ ‎‡9  1‏
919 ‎‡a  complementaryandalternativemedicinesusebyscottishwomenwithbreastcancerwhatwhyandthepotentialfordruginteractions‏ ‎‡A  Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?‏ ‎‡9  1‏
919 ‎‡a  copd10australianandnewzealandguidelinesforthediagnosisandmanagementofchronicobstructivepulmonarydisease2017update‏ ‎‡A  COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update‏ ‎‡9  1‏
919 ‎‡a  crosssectionalsurveyofthescottishgeneralpublicsawarenessofviewsonandattitudestowardnonmedicalprescribing‏ ‎‡A  Cross sectional survey of the Scottish general public's awareness of, views on, and attitudes toward nonmedical prescribing‏ ‎‡9  1‏
919 ‎‡a  developingandvalidatingatoolforassessmentofpharmacistprescribersconsultations‏ ‎‡A  Developing and validating a tool for assessment of pharmacist prescribers' consultations‏ ‎‡9  1‏
919 ‎‡a  developmentandvalidationofa21itemchallengestostoppingsmokingcss21scale‏ ‎‡A  Development and validation of a 21-item challenges to stopping smoking (CSS-21) scale‏ ‎‡9  1‏
919 ‎‡a  developmentandvalidationofthebeliefsandbehaviourquestionnaire‏ ‎‡A  Development and validation of the Beliefs and Behaviour Questionnaire‏ ‎‡9  1‏
919 ‎‡a  developmentandvalidationofthebeliefsandbehaviourquestionnairebbq‏ ‎‡A  Development and validation of the Beliefs and Behaviour Questionnaire (BBQ).‏ ‎‡9  1‏
919 ‎‡a  developmentandvalidationofthemedicationbaseddiseaseburdenindex‏ ‎‡A  Development and validation of the medication-based disease burden index.‏ ‎‡9  1‏
919 ‎‡a  developmentandvalidationofthemedicationregimencomplexityindex‏ ‎‡A  Development and Validation of the Medication Regimen Complexity Index‏ ‎‡9  1‏
919 ‎‡a  developmentofanonlinesmokingcessationprogramforuseinhospitalandfollowingdischargesmokefreerecovery‏ ‎‡A  Development of an online smoking cessation program for use in hospital and following discharge: smoke-free recovery‏ ‎‡9  1‏
919 ‎‡a  diagnosingcopdandsupportingsmokingcessationingeneralpracticeevidencepracticegaps‏ ‎‡A  Diagnosing COPD and supporting smoking cessation in general practice: evidence-practice gaps‏ ‎‡9  1‏
919 ‎‡a  dietarysupplementuseinolderpeopleattendingmemoryclinicsinaustralia‏ ‎‡A  Dietary Supplement Use in Older People Attending Memory Clinics in Australia‏ ‎‡9  1‏
919 ‎‡a  educatingnonmedicalprescribers‏ ‎‡A  Educating nonmedical prescribers‏ ‎‡9  1‏
919 ‎‡a  engagingcommunitypharmacistsintheprimarypreventionofcardiovasculardiseaseprotocolforthepharmacistassessmentofadherenceriskandtreatmentincardiovasculardiseasepaartcvdpilotstudy‏ ‎‡A  Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study‏ ‎‡9  1‏
919 ‎‡a  evaluationofacommunitypharmacybasedinterventionforimprovingpatientadherencetoantihypertensivesarandomisedcontrolledtrial‏ ‎‡A  Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial.‏ ‎‡9  1‏
919 ‎‡a  experientiallearningaspartofpharmacistsupplementaryprescribingtrainingfeedbackfromtraineesandtheirmentors‏ ‎‡A  Experiential learning as part of pharmacist supplementary prescribing training: feedback from trainees and their mentors‏ ‎‡9  1‏
919 ‎‡a  exploringpatientsperspectivesofpharmacistsupplementaryprescribinginscotland‏ ‎‡A  Exploring patients' perspectives of pharmacist supplementary prescribing in Scotland.‏ ‎‡9  1‏
919 ‎‡a  exploringstakeholderperspectivesonmedicationreviewservicesforolderresidentsinretirementvillages‏ ‎‡A  Exploring stakeholder perspectives on medication review services for older residents in retirement villages‏ ‎‡9  1‏
919 ‎‡a  factorsassociatedwithmedicationnonadherenceinpatientswithcopd‏ ‎‡A  Factors associated with medication nonadherence in patients with COPD.‏ ‎‡9  1‏
919 ‎‡a  factorsassociatedwithnicotinereplacementtherapyuseamonghospitalisedsmokers‏ ‎‡A  Factors associated with nicotine replacement therapy use among hospitalised smokers‏ ‎‡9  1‏
919 ‎‡a  hospitalsmokefreepolicycomplianceenforcementandpracticesastaffsurveyin2largepublichospitalsinaustralia‏ ‎‡A  Hospital Smoke-Free Policy: Compliance, Enforcement, and Practices. A Staff Survey in Two Large Public Hospitals in Australia‏ ‎‡9  1‏
919 ‎‡a  impactofaselfadministrationofmedicationsprogrammeonelderlyinpatientscompetencetomanagemedicationsapilotstudy‏ ‎‡A  Impact of a self-administration of medications programme on elderly inpatients' competence to manage medications: a pilot study‏ ‎‡9  1‏
919 ‎‡a  impactofaninterventiontoreducemedicationregimencomplexityforolderhospitalinpatients‏ ‎‡A  Impact of an intervention to reduce medication regimen complexity for older hospital inpatients.‏ ‎‡9  1‏
919 ‎‡a  improvingosteoporosismanagementingeneralpracticeapharmacistleddruguseevaluationprogram‏ ‎‡A  Improving osteoporosis management in general practice: a pharmacist-led drug use evaluation program‏ ‎‡9  1‏
919 ‎‡a  independentprescribingbypharmacistsastudyoftheawarenessviewsandattitudesofscottishcommunitypharmacists‏ ‎‡A  Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists‏ ‎‡9  1‏
919 ‎‡a  integratingsmokingcessationintoroutinecareinhospitalsarandomizedcontrolledtrial‏ ‎‡A  Integrating smoking cessation into routine care in hospitals--a randomized controlled trial‏ ‎‡9  1‏
919 ‎‡a  integrationofpharmacistsintogeneralpracticeclinicsinaustraliatheviewsofgeneralpractitionersandpharmacists‏ ‎‡A  Integration of pharmacists into general practice clinics in Australia: the views of general practitioners and pharmacists.‏ ‎‡9  1‏
919 ‎‡a  interdisciplinarycopdinterventioninprimarycareaclusterrandomisedcontrolledtrial‏ ‎‡A  Interdisciplinary COPD intervention in primary care: a cluster randomised controlled trial‏ ‎‡9  1‏
919 ‎‡a  pulmonaryandsystemicpharmacokineticsofinhaledandintravenouscolistinmethanesulfonateincysticfibrosispatientstargetingadvantageofinhalationaladministration‏ ‎‡A  Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.‏ ‎‡9  1‏
919 ‎‡a  quittingexperiencesandpreferencesforafuturequitattemptastudyamonginpatientsmokers‏ ‎‡A  Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers‏ ‎‡9  1‏
919 ‎‡a  riskfactorsformedicationmisadventureamongresidentsinshelteredhousingcomplexes‏ ‎‡A  Risk factors for medication misadventure among residents in sheltered housing complexes‏ ‎‡9  1‏
919 ‎‡a  selfmonitoringofbloodpressureinhypertensionasystematicreviewandindividualpatientdatametaanalysis‏ ‎‡A  Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis.‏ ‎‡9  1‏
919 ‎‡a  smokefreerecoveryfromtraumasurgeryapilottrialofanonlinesmokingcessationprogramfororthopaedictraumapatients‏ ‎‡A  Smoke-Free Recovery from Trauma Surgery: A Pilot Trial of an Online Smoking Cessation Program for Orthopaedic Trauma Patients‏ ‎‡9  1‏
919 ‎‡a  smokingquittingandtheprovisionofsmokingcessationsupportasurveyoforthopaedictraumapatients‏ ‎‡A  Smoking, Quitting, and the Provision of Smoking Cessation Support: A Survey of Orthopaedic Trauma Patients‏ ‎‡9  1‏
919 ‎‡a  smokingratesandsmokingcessationpreferencesofpregnantwomenattendingantenatalclinicsof2largeaustralianmaternityhospitals‏ ‎‡A  Smoking rates and smoking cessation preferences of pregnant women attending antenatal clinics of two large Australian maternity hospitals‏ ‎‡9  1‏
919 ‎‡a  stakeholderexperienceswithgeneralpracticepharmacistservicesaqualitativestudy‏ ‎‡A  Stakeholder experiences with general practice pharmacist services: a qualitative study‏ ‎‡9  1‏
919 ‎‡a  studyprotocolforarandomisedcontrolledtrialevaluatingtheefficacyofatelehealthprogrammanagementofasthmawithsupportivetelehealthofrespiratoryfunctioninpregnancymastery‏ ‎‡A  Study protocol for a randomised controlled trial evaluating the efficacy of a telehealth program--management of asthma with supportive telehealth of respiratory function in pregnancy (MASTERY©).‏ ‎‡9  1‏
919 ‎‡a  supplementaryprescribingearlyexperiencesofpharmacistsingreatbritain‏ ‎‡A  Supplementary prescribing: early experiences of pharmacists in Great Britain‏ ‎‡9  1‏
919 ‎‡a  systemchangeinterventionsforsmokingcessation‏ ‎‡A  System change interventions for smoking cessation.‏ ‎‡9  1‏
919 ‎‡a  systematicreviewofthesafetyofregularpreventiveasthmamedicationsduringpregnancy‏ ‎‡A  Systematic review of the safety of regular preventive asthma medications during pregnancy‏ ‎‡9  1‏
919 ‎‡a  tacklingtobaccosmokingopportunitiesforpharmacists‏ ‎‡A  Tackling tobacco smoking: opportunities for pharmacists‏ ‎‡9  1‏
919 ‎‡a  telehealthtoimproveasthmacontrolinpregnancyarandomizedcontrolledtrial‏ ‎‡A  Telehealth to improve asthma control in pregnancy: A randomized controlled trial‏ ‎‡9  1‏
919 ‎‡a  effectivenessofnonpharmacologicalhealthcareinterventionsforasthmamanagementduringpregnancyasystematicreview‏ ‎‡A  The effectiveness of non-pharmacological healthcare interventions for asthma management during pregnancy: a systematic review‏ ‎‡9  1‏
919 ‎‡a  potentialroleofpharmacistsinchronicdiseasescreening‏ ‎‡A  The potential role of pharmacists in chronic disease screening‏ ‎‡9  1‏
919 ‎‡a  prevalenceandnatureofmedicationerrorsandadverseeventsrelatedtopreadmissionmedicationswhenpatientsareadmittedtoanorthopedicinpatientunitanobservationalstudy‏ ‎‡A  The Prevalence and Nature of Medication Errors and Adverse Events Related to Preadmission Medications When Patients Are Admitted to an Orthopedic Inpatient Unit: An Observational Study‏ ‎‡9  1‏
919 ‎‡a  rolesofcommunitypharmacistsincardiovasculardiseasepreventionandmanagement‏ ‎‡A  The roles of community pharmacists in cardiovascular disease prevention and management.‏ ‎‡9  1‏
919 ‎‡a  treatabletraitsinanenglishcohortprevalenceandpredictorsoffuturedeclineinlungfunctionandqualityoflifeincopd‏ ‎‡A  Treatable traits in an English cohort: prevalence and predictors of future decline in lung function and quality of life in COPD‏ ‎‡9  1‏
919 ‎‡a  uptakeandeffectivenessofacommunitypharmacyinterventionprogrammetoimproveasthmamanagement‏ ‎‡A  Uptake and effectiveness of a community pharmacy intervention programme to improve asthma management.‏ ‎‡9  1‏
919 ‎‡a  viewsofpharmacistprescribersdoctorsandpatientsonpharmacistprescribingimplementation‏ ‎‡A  Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation.‏ ‎‡9  1‏
919 ‎‡a  interdisciplinarymodelofcareradicalsforearlydetectionandmanagementofchronicobstructivepulmonarydiseasecopdinaustralianprimarycarestudyprotocolforaclusterrandomisedcontrolledtrial‏ ‎‡A  Interdisciplinary model of care (RADICALS) for early detection and management of chronic obstructive pulmonary disease (COPD) in Australian primary care: study protocol for a cluster randomised controlled trial‏ ‎‡9  1‏
919 ‎‡a  interventionfidelityforacomplexbehaviourchangeinterventionincommunitypharmacyaddressingcardiovasculardiseaserisk‏ ‎‡A  Intervention fidelity for a complex behaviour change intervention in community pharmacy addressing cardiovascular disease risk.‏ ‎‡9  1‏
919 ‎‡a  interventionsforimprovingmedicationtakingabilityandadherenceinolderadultsprescribedmultiplemedications‏ ‎‡A  Interventions for improving medication‐taking ability and adherence in older adults prescribed multiple medications.‏ ‎‡9  1‏
919 ‎‡a  managementofasthmabypregnantwomenattendinganaustralianmaternityhospital‏ ‎‡A  Management of asthma by pregnant women attending an Australian maternity hospital‏ ‎‡9  1‏
919 ‎‡a  managementofasthmainpregnantwomenbygeneralpractitionersacrosssectionalsurvey‏ ‎‡A  Management of asthma in pregnant women by general practitioners: a cross sectional survey‏ ‎‡9  1‏
919 ‎‡a  managementofpregnanciescomplicatedbyhypertensivedisordersofpregnancycouldwedobetter‏ ‎‡A  Management of pregnancies complicated by hypertensive disorders of pregnancy: Could we do better?‏ ‎‡9  1‏
919 ‎‡a  medicationmanagementforcommunitypalliativecarepatientsandtheroleofaspecialistpalliativecarepharmacistaqualitativeexplorationofconsumerandhealthcareprofessionalperspectives‏ ‎‡A  Medication management for community palliative care patients and the role of a specialist palliative care pharmacist: A qualitative exploration of consumer and health care professional perspectives‏ ‎‡9  1‏
919 ‎‡a  medicationuseforchronichealthconditionsbypregnantwomenattendinganaustralianmaternityhospital‏ ‎‡A  Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital‏ ‎‡9  1‏
919 ‎‡a  multidisciplinaryapproachtomanagementofmaternalasthma‏ ‎‡A  Multidisciplinary Approach to Management of Maternal Asthma‏ ‎‡9  1‏
919 ‎‡a  multidisciplinaryapproachtomanagementofmaternalasthmamamma‏ ‎‡A  Multidisciplinary Approach to Management of Maternal Asthma (MAMMA)‏ ‎‡9  1‏
919 ‎‡a  multidisciplinaryapproachtomanagementofmaternalasthmamammatheprotocolforarandomizedcontrolledtrial‏ ‎‡A  Multidisciplinary approach to management of maternal asthma (MAMMA [copyright]): the PROTOCOL for a randomized controlled trial‏ ‎‡9  1‏
919 ‎‡a  viewsofpharmacistsandmentorsonexperientiallearningforpharmacistsupplementaryprescribingtrainees‏ ‎‡A  Views of pharmacists and mentors on experiential learning for pharmacist supplementary prescribing trainees.‏ ‎‡9  1‏
919 ‎‡a  nicotinereplacementtherapyevidencefromobservationalstudiesversusclinicaltrials‏ ‎‡A  Nicotine replacement therapy: evidence from observational studies versus clinical trials‏ ‎‡9  1‏
919 ‎‡a  nonmedicalprescribingversusmedicalprescribingforacuteandchronicdiseasemanagementinprimaryandsecondarycare‏ ‎‡A  Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.‏ ‎‡9  1‏
919 ‎‡a  viewsofthescottishgeneralpubliconnonmedicalprescribing‏ ‎‡A  Views of the Scottish general public on non-medical prescribing‏ ‎‡9  1‏
919 ‎‡a  optimisingmedicationuseduringpregnancythepotentialroleofpharmacists‏ ‎‡A  Optimising medication use during pregnancy: the potential role of pharmacists‏ ‎‡9  1‏
919 ‎‡a  pharmacistconsultationassessmenttool‏ ‎‡A  Pharmacist Consultation Assessment Tool‏ ‎‡9  1‏
919 ‎‡a  whoismorelikelytousetheinternetforhealthbehaviorchangeacrosssectionalsurveyofinternetuseamongsmokersandnonsmokerswhoareorthopedictraumapatients‏ ‎‡A  Who is More Likely to Use the Internet for Health Behavior Change? A Cross-Sectional Survey of Internet Use Among Smokers and Nonsmokers Who Are Orthopedic Trauma Patients.‏ ‎‡9  1‏
919 ‎‡a  pharmacistconsultationsingeneralpracticeclinicsthepharmacistsinpracticestudypips‏ ‎‡A  Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).‏ ‎‡9  1‏
919 ‎‡a  pharmacistprescribinginprimarycaretheviewsofpatientsacrossgreatbritainwhohadexperiencedtheservice‏ ‎‡A  Pharmacist prescribing in primary care: the views of patients across Great Britain who had experienced the service‏ ‎‡9  1‏
919 ‎‡a  pharmacistservicesprovidedingeneralpracticeclinicsasystematicreviewandmetaanalysis‏ ‎‡A  Pharmacist services provided in general practice clinics: a systematic review and meta-analysis.‏ ‎‡9  1‏
919 ‎‡a  pharmacistsupplementaryprescribingtrainingastudyofpharmacistsperceptionsandplannedparticipation‏ ‎‡A  Pharmacist supplementary prescribing training: a study of pharmacists' perceptions and planned participation‏ ‎‡9  1‏
919 ‎‡a  potentiallyinappropriatemedicationanticholinergicburdenandmortalityinpeopleattendingmemoryclinics‏ ‎‡A  Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics‏ ‎‡9  1‏
919 ‎‡a  potentiallyinappropriatemedicationsandanticholinergicburdeninolderpeopleattendingmemoryclinicsinaustralia‏ ‎‡A  Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia‏ ‎‡9  1‏
919 ‎‡a  prescriptionmedicationsbeliefsexperiencesbehaviorandadherenceofshelteredhousingresidents‏ ‎‡A  Prescription medications: beliefs, experiences, behavior, and adherence of sheltered housing residents‏ ‎‡9  1‏
919 ‎‡a  prevalenceofmedicationrelatedriskfactorsamongretirementvillageresidentsacrosssectionalsurvey‏ ‎‡A  Prevalence of medication-related risk factors among retirement village residents: a cross-sectional survey‏ ‎‡9  1‏
919 ‎‡a  clinicaloutcomesassociatedwithmedicationregimencomplexityinolderpeopleasystematicreview‏ ‎‡A  Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review.‏ ‎‡9  1‏
919 ‎‡a  challengesinmeasuringmedicationadherenceexperiencesfromacontrolledtrial‏ ‎‡A  Challenges in measuring medication adherence: experiences from a controlled trial‏ ‎‡9  1‏
919 ‎‡a  canaredesignofemergencypharmacistrolesimprovemedicationmanagementaprospectivestudyin3australianhospitals‏ ‎‡A  Can a redesign of emergency pharmacist roles improve medication management? A prospective study in three Australian hospitals.‏ ‎‡9  1‏
919 ‎‡a  benefitsandchallengesofprescribingtrainingandimplementationperceptionsandearlyexperiencesofrpsgbprescribers‏ ‎‡A  Benefits and challenges of prescribing training and implementation: perceptions and early experiences of RPSGB prescribers‏ ‎‡9  1‏
943 ‎‡a  201x‏ ‎‡A  2017‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  LC|no2021026504‏
996 ‎‡2  LC|n 87144762‏
996 ‎‡2  J9U|987007437053005171‏
996 ‎‡2  SUDOC|077931831‏
996 ‎‡2  DNB|1119809185‏
996 ‎‡2  CAOONL|ncf10293914‏
996 ‎‡2  LC|no2014012831‏
996 ‎‡2  LC|n 2015191415‏
996 ‎‡2  ISNI|0000000512513070‏
996 ‎‡2  LC|nb 99182844‏
996 ‎‡2  ISNI|0000000076002740‏
996 ‎‡2  ISNI|000000007613484X‏
996 ‎‡2  J9U|987007447349605171‏
996 ‎‡2  J9U|987007369153605171‏
996 ‎‡2  ISNI|0000000034403925‏
996 ‎‡2  SUDOC|232287767‏
996 ‎‡2  DNB|1090653247‏
996 ‎‡2  JPG|500141309‏
996 ‎‡2  NUKAT|n 01044536‏
996 ‎‡2  PLWABN|9810599408305606‏
996 ‎‡2  ISNI|0000000025487741‏
996 ‎‡2  DNB|1027674992‏
996 ‎‡2  RERO|A027046222‏
996 ‎‡2  DNB|142484288‏
996 ‎‡2  BIBSYS|90109061‏
996 ‎‡2  J9U|987007396889705171‏
996 ‎‡2  ISNI|0000000081806575‏
996 ‎‡2  J9U|987007399019605171‏
996 ‎‡2  LC|n 85115784‏
996 ‎‡2  ISNI|0000000084673675‏
996 ‎‡2  ISNI|0000000027760959‏
996 ‎‡2  ISNI|0000000499885776‏
996 ‎‡2  NUKAT|n 2008133977‏
996 ‎‡2  LC|n 92064655‏
996 ‎‡2  CAOONL|ncf10969830‏
996 ‎‡2  NDL|00708855‏
996 ‎‡2  ISNI|0000000061365899‏
996 ‎‡2  LC|n 95099229‏
996 ‎‡2  ISNI|0000000446442402‏
996 ‎‡2  ISNI|000000004556461X‏
996 ‎‡2  CAOONL|ncf13746271‏
996 ‎‡2  JPG|500141313‏
996 ‎‡2  SUDOC|076623556‏
996 ‎‡2  LC|n 99037422‏
996 ‎‡2  NUKAT|n 2011201444‏
996 ‎‡2  NTA|165504226‏
996 ‎‡2  LC|n 87936038‏
996 ‎‡2  NII|DA07223058‏
996 ‎‡2  ISNI|0000000031510450‏
996 ‎‡2  NUKAT|n 2012166171‏
996 ‎‡2  ISNI|0000000039858312‏
996 ‎‡2  ISNI|0000000116267736‏
996 ‎‡2  ISNI|0000000448809386‏
996 ‎‡2  ISNI|0000000043218799‏
996 ‎‡2  PTBNP|172408‏
996 ‎‡2  BNF|17130136‏
996 ‎‡2  PLWABN|9810612302305606‏
996 ‎‡2  NKC|vut2012705387‏
996 ‎‡2  LC|n 88630842‏
996 ‎‡2  NII|DA08950921‏
996 ‎‡2  LC|n 85815871‏
996 ‎‡2  LC|no2015059400‏
996 ‎‡2  NTA|069414084‏
996 ‎‡2  LC|n 84212548‏
996 ‎‡2  ISNI|0000000103534700‏
996 ‎‡2  ISNI|0000000036061607‏
996 ‎‡2  ISNI|0000000054911943‏
996 ‎‡2  ISNI|0000000032020103‏
996 ‎‡2  J9U|987007293260505171‏
996 ‎‡2  LC|n 2008053906‏
996 ‎‡2  ISNI|0000000032169477‏
996 ‎‡2  LC|n 95050826‏
996 ‎‡2  J9U|987007261504805171‏
996 ‎‡2  LC|n 2010045508‏
996 ‎‡2  ISNI|0000000116983070‏
996 ‎‡2  J9U|987007439535505171‏
996 ‎‡2  LC|no2023071937‏
996 ‎‡2  LC|n 82119743‏
996 ‎‡2  ISNI|0000000110411047‏
996 ‎‡2  SUDOC|140352619‏
996 ‎‡2  LC|no2002111674‏
996 ‎‡2  DNB|102117470‏
996 ‎‡2  LC|n 82037124‏
996 ‎‡2  BIBSYS|11020841‏
996 ‎‡2  ISNI|0000000067302573‏
996 ‎‡2  NII|DA02651087‏
996 ‎‡2  DNB|102816964‏
996 ‎‡2  CAOONL|ncf10143161‏
996 ‎‡2  ISNI|0000000024181863‏
996 ‎‡2  ISNI|0000000068903565‏
996 ‎‡2  ISNI|0000000074715034‏
996 ‎‡2  BNF|12459391‏
996 ‎‡2  ISNI|0000000038604986‏
996 ‎‡2  LC|n 81138091‏
996 ‎‡2  ISNI|000000010976286X‏
996 ‎‡2  LC|n 85158213‏
996 ‎‡2  NTA|071111751‏
996 ‎‡2  ISNI|0000000029488143‏
996 ‎‡2  DNB|133492613‏
996 ‎‡2  NTA|069264783‏
996 ‎‡2  J9U|987007326012505171‏
996 ‎‡2  JPG|500001359‏
996 ‎‡2  LC|no2009101222‏
996 ‎‡2  NTA|159572150‏
996 ‎‡2  J9U|987007327752805171‏
996 ‎‡2  ISNI|0000000032300383‏
996 ‎‡2  J9U|987007279202105171‏
996 ‎‡2  LC|n 91067748‏
996 ‎‡2  LC|no2022022791‏
996 ‎‡2  J9U|987007425405705171‏
996 ‎‡2  BNF|14403671‏
996 ‎‡2  ISNI|0000000084001246‏
996 ‎‡2  N6I|vtls001354192‏
996 ‎‡2  RERO|A022951078‏
996 ‎‡2  ISNI|0000000035129446‏
996 ‎‡2  BNF|16356750‏
996 ‎‡2  CAOONL|ncf11720625‏
996 ‎‡2  BNF|18064536‏
996 ‎‡2  NUKAT|n 2011106211‏
996 ‎‡2  ISNI|0000000116845962‏
996 ‎‡2  LC|n 2004096539‏
996 ‎‡2  SUDOC|066825776‏
996 ‎‡2  LC|n 87838126‏
996 ‎‡2  RERO|A013615379‏
996 ‎‡2  RERO|A003288980‏
996 ‎‡2  ISNI|0000000036551550‏
996 ‎‡2  LC|no2020103038‏
996 ‎‡2  NTA|071138447‏
996 ‎‡2  LC|n 79017231‏
996 ‎‡2  LC|no 93038111‏
996 ‎‡2  LC|no2005018702‏
996 ‎‡2  NSK|000171491‏
996 ‎‡2  ISNI|000000005077892X‏
996 ‎‡2  LC|no2019078793‏
996 ‎‡2  LC|n 2002015238‏
996 ‎‡2  PLWABN|9810650721505606‏
996 ‎‡2  BIBSYS|7004168‏
996 ‎‡2  ISNI|0000000027096701‏
996 ‎‡2  NUKAT|n 2011046298‏
996 ‎‡2  LC|n 81130149‏
996 ‎‡2  JPG|500004590‏
996 ‎‡2  J9U|987007272837105171‏
996 ‎‡2  CAOONL|ncf11498535‏
996 ‎‡2  ISNI|0000000037153204‏
996 ‎‡2  LC|n 86036579‏
996 ‎‡2  LC|n 87896988‏
996 ‎‡2  NKC|mub2013741917‏
996 ‎‡2  LC|no2018171536‏
996 ‎‡2  LC|n 91034972‏
996 ‎‡2  LC|n 86030452‏
996 ‎‡2  LC|n 98011774‏
996 ‎‡2  NII|DA07565302‏
996 ‎‡2  LC|nb2002033230‏
996 ‎‡2  CAOONL|ncf10143791‏
996 ‎‡2  DNB|1146200285‏
996 ‎‡2  LC|n 83164074‏
996 ‎‡2  LC|n 2007078511‏
996 ‎‡2  CAOONL|ncf10596950‏
996 ‎‡2  JPG|500017313‏
996 ‎‡2  J9U|987007347568405171‏
996 ‎‡2  NTA|159572657‏
996 ‎‡2  SUDOC|082955042‏
996 ‎‡2  DNB|100029752‏
996 ‎‡2  CAOONL|ncf11898909‏
996 ‎‡2  LC|n 80003737‏
996 ‎‡2  LC|n 2010004368‏
996 ‎‡2  SUDOC|252226704‏
996 ‎‡2  ISNI|0000000389188160‏
996 ‎‡2  BIBSYS|90057708‏
996 ‎‡2  BNF|12329797‏
996 ‎‡2  LC|n 2014015502‏
996 ‎‡2  ISNI|0000000384344857‏
996 ‎‡2  ISNI|0000000394893016‏
996 ‎‡2  SUDOC|079173160‏
996 ‎‡2  BIBSYS|90134580‏
996 ‎‡2  ISNI|0000000033945642‏
996 ‎‡2  NKC|ntk20201063694‏
996 ‎‡2  ISNI|0000000123848088‏
996 ‎‡2  LC|no2010053562‏
996 ‎‡2  LC|n 80007473‏
996 ‎‡2  ISNI|0000000114824412‏
996 ‎‡2  ISNI|0000000097224748‏
996 ‎‡2  DNB|1089152973‏
996 ‎‡2  LC|no2017041242‏
996 ‎‡2  SUDOC|153447575‏
996 ‎‡2  ISNI|0000000430347064‏
996 ‎‡2  BIBSYS|4108515‏
996 ‎‡2  N6I|vtls001327321‏
996 ‎‡2  J9U|987007376754105171‏
996 ‎‡2  DNB|170390780‏
996 ‎‡2  LC|n 96009602‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏
998 ‎‡a  Johnson, George‏ ‎‡2  RERO|A013773993‏ ‎‡3  exact name‏
998 ‎‡a  Johnson, George‏ ‎‡2  CAOONL|ncf12076771‏ ‎‡3  exact name‏
998 ‎‡a  Johnson, George‏ ‎‡2  LC|n 89638575‏ ‎‡3  exact name‏
998 ‎‡a  Johnson, George‏ ‎‡2  PLWABN|9810587073405606‏ ‎‡3  exact name‏
998 ‎‡a  Johnson, George‏ ‎‡2  NTA|070401969‏ ‎‡3  exact name‏
998 ‎‡a  Johnson, George‏ ‎‡2  BAV|495_366006‏ ‎‡3  exact name‏
998 ‎‡a  Johnson, George‏ ‎‡2  BIBSYS|90359038‏ ‎‡3  exact name‏
998 ‎‡a  Johnson, George‏ ‎‡2  NSK|000628928‏ ‎‡3  exact name‏
998 ‎‡a  Johnson, George‏ ‎‡2  B2Q|0000425788‏ ‎‡3  exact name‏
998 ‎‡a  Johnson‏ ‎‡b  George‏ ‎‡2  LIH|LNB:C91E;=_m_7‏ ‎‡3  exact name‏
998 ‎‡a  Johnson, George‏ ‎‡2  DBC|87097991129604‏ ‎‡3  exact name‏